ARNIssodium glucose co-transporter-2 inhibitorsSGLT2iSGLT2MRAmineralocorticoid receptor antagonistsDCMdilated cardiomyopathy
…in TRED-HF received angiotensin receptor–neprilysin inhibitors (ARNIs) or SGLT2 inhibitors, compared with 61% and 63% of TRED-HF2 pat…